March 6, 2018 / 9:42 PM / 4 months ago

BRIEF-Editas Medicine Q4 Loss Per Share $0.84

March 6 (Reuters) - Editas Medicine Inc:

* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND UPDATE

* Q4 LOSS PER SHARE $0.84

* EDITAS MEDICINE - EDIT-101 FOR LEBER CONGENITAL AMAUROSIS TYPE 10 ON TRACK FOR MID-2018 INVESTIGATIONAL NEW DRUG FILING

* YEAR-END CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $329 MILLION EXPECTED TO FUND BUSINESS FOR AT LEAST 24 MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below